Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life

• Published in: American journal of medical genetics. Part A 2015-09, Vol.167A (9), p.2103-2113
• Main Authors: Wolters, Pamela L., Burns, Katherine M., Martin, Staci, Baldwin, Andrea, Dombi, Eva, Toledo-Tamula, Mary Anne, Dudley, William N., Gillespie, Andrea, Widemann, Brigitte C.
• Format: Article
• Language: English
• Subjects: Adaptation, Psychological - physiology; Adolescent; Caregivers - psychology; Child; children; Emotions - physiology; Female; Humans; Male; Mental Disorders - pathology; Mental Disorders - psychology; Neurofibroma, Plexiform - complications; Neurofibroma, Plexiform - pathology; Neurofibroma, Plexiform - psychology; Neurofibromatosis 1 - complications; Neurofibromatosis 1 - pathology; Neurofibromatosis 1 - psychology; neurofibromatosis type 1; pain; Pain - etiology; Pain - pathology; Pain - psychology; plexiform neurofibromas; Quality of Life; Severity of Illness Index; Surveys and Questionnaires
• ISSN: 1552-4825; 1552-4833; 1552-4833
• DOI: 10.1002/ajmg.a.37123

The physical manifestations of neurofibromatosis type 1 (NF1) can cause chronic pain. This study investigated the impact of pain in youth with NF1 and plexiform neurofibromas (PNs) and its relationship to disease factors, social‐emotional functioning, and quality of life (QOL) within a biopsychosocial framework. Caregivers of 59 children and adolescents with NF1 and PNs (6–18 years), and 41 of these youth (10–18 years), completed questionnaires assessing social‐emotional functioning and QOL, including an item on pain interference. Measures of disease severity included total PN volume by percent body weight and number of disease complications. Both caregiver (73%) and self‐report (59%) ratings indicated that pain interferes with the child's daily functioning despite 33% taking pain medication. Based on caregivers’ behavior ratings, more symptoms of anxiety and larger tumor volumes predicted greater pain interference, while greater pain interference, worse depressive symptoms, and more disease complications predicted poorer QOL. As rated by adolescents, more symptoms of anxiety predicted greater pain interference, while greater pain interference and social stress predicted poorer QOL. Further, social‐emotional problems mediate the relationship between pain interference and QOL. Thus, pain interferes with daily functioning in the majority of youth with NF1 and PNs even when using pain medication. The impact of pain interference, disease severity, and particularly social‐emotional problems on QOL highlights the interaction between physical and psychological states in NF1. Future research and treatment of pain in this population should utilize a biopsychosocial approach and involve multidisciplinary therapies including psychological interventions that target social‐emotional functioning. © 2015 Wiley Periodicals, Inc.